1. Academic Validation
  2. Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer

Cullin-5 neddylation-mediated NOXA degradation is enhanced by PRDX1 oligomers in colorectal cancer

  • Cell Death Dis. 2021 Mar 12;12(3):265. doi: 10.1038/s41419-021-03557-3.
Shoufang Xu  # 1 2 Yilei Ma  # 1 2 Qingchao Tong 1 2 Jun Yang 1 3 4 Jia Liu 1 2 Yanzhong Wang 1 2 Guoli Li 1 2 Jin Zeng 1 2 Sining Fang 1 2 Fengying Li 1 2 Xinyou Xie 5 6 Jun Zhang 7 8
Affiliations

Affiliations

  • 1 Department of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China.
  • 2 Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, Zhejiang, P.R. China.
  • 3 Department of Cytopathology, Ningbo Diagnostic Pathology Center, Ningbo, Zhejiang, P.R. China.
  • 4 Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, P. R. China.
  • 5 Department of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China. scottxie@zju.edu.cn.
  • 6 Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, Zhejiang, P.R. China. scottxie@zju.edu.cn.
  • 7 Department of Clinical Laboratory, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China. jameszhang2000@zju.edu.cn.
  • 8 Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, Zhejiang, P.R. China. jameszhang2000@zju.edu.cn.
  • # Contributed equally.
Abstract

NOXA, a BH3-only proapoptotic protein involved in regulating cell death decisions, is highly expressed but short-lived in colorectal Cancer (CRC). Neddylated cullin-5 (CUL5)-mediated ubiquitination and degradation of NOXA is crucial to prevent its overaccumulation and maintain an appropriate action time. However, how this process is manipulated by CRC cells commonly exposed to oxidative stress remain unknown. The peroxiredoxin PRDX1, a conceivable antioxidant overexpressed in CRC tissues, has been shown to inhibit Apoptosis and TRAF6 ubiquitin-ligase activity. In this study, we found that PRDX1 inhibits CRC cell Apoptosis by downregulating NOXA. Mechanistically, PRDX1 promotes NOXA ubiquitination and degradation, which completely depend on CUL5 neddylation. Further studies have demonstrated that PRDX1 oligomers bind with both the Nedd8-conjugating Enzyme UBE2F and CUL5 and that this tricomplex is critical for CUL5 neddylation, since silencing PRDX1 or inhibiting PRDX1 oligomerization greatly dampens CUL5 neddylation and NOXA degradation. An increase in Reactive Oxygen Species (ROS) is not only a hallmark of Cancer cells but also the leading driving force for PRDX1 oligomerization. As shown in our study, although ROS play a role in upregulating NOXA mRNA transcription, ROS scavenging in CRC cells by N-acetyl-L-cysteine (NAC) can significantly reduce CUL5 neddylation and extend the NOXA protein half-life. Therefore, in CRC, PRDX1 plays a key role in maintaining intracellular homeostasis under conditions of high metabolic activity by reinforcing UBE2F-CUL5-mediated degradation of NOXA, which is also evidenced in the resistance of CRC cells to etoposide treatment. Based on these findings, targeting PRDX1 could be an effective strategy to overcome the resistance of CRC to DNA damage-inducing chemotherapeutics.

Figures
Products